Skip to content
Flamma logo — Family owned & run. Advancing amino acids & small molecules...

Flamma

Family owned & run. Advancing amino acids & small molecules since 1950. See why FLAMMA is The Thinking CDMO & follow us

Founded 1950 Italy Italy 452 employees Biotechnology, Manufacturing +1

General Information

Company Name Flamma
Founded Year 1950
Location Italy Italy
Employees 452
Industries Biotechnology, Manufacturing, Pharmaceutical
Business Model B2B, D2C
Revenue Model Service Fee, Product Sales, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with Flamma. To contact Flamma, visit flammagroup.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Flamma compare?

A PDF of Flamma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Flamma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Flamma

Flamma, established in 1950, is a distinguished, family-owned, award-winning CDMO (Contract Development and Manufacturing Organization) with its headquarters situated near Milan, Italy. Operating in the Biotechnology, Manufacturing, and Pharmaceutical industries, Flamma has carved out a niche in the cGMP manufacturing of small molecule APIs, NCEs, RSMs, and advanced intermediates, particularly excelling in high-value chiral materials used in peptide drugs.

Flamma's extensive capabilities range from early-stage pre-clinical development in its Philadelphia facility to large-scale commercial manufacturing across three sites in Italy and one in Dalian, China. With over 1,000 employees and a combined production capacity of 1,300 m3, Flamma provides a comprehensive manufacturing solution for the entire life cycle of a small molecule drug.

Notably, Flamma has not listed any recent investments, implying a focus on stable growth and leveraging its longstanding industry reputation as The Thinking CDMO™.

Business keywords: cGMP manufacturing, small molecule APIs, NCEs, RSMs, advanced intermediates, high value chiral materials, amino acid chemistry, peptide drugs, early stage pre-clinical development, large-scale commercial manufacturing, custom API development, process R&D, secure supply chain, family owned, award winning

Services & Products

Custom Manufacturing
Process Development
Analytical Validation
Commercial Manufacturing
Scale-up Capabilities
Regulatory Support

Target Customers

Pharmaceutical Companies Biotech Firms Drug Development Companies API Manufacturers

No funding data available for Flamma yet.

Flamma Alternatives & Competitors

View All Alternatives
Flamma vs

Your Integrated CDMO Specialist. Driven by experts, led by science.

Private Equity
123 employees
Biotechnology, Industrial
Flamma vs

CDMO focused on sterile injectable drug products with FDA-approved facility prioritizing speed, flex...

107 employees
Manufacturing, Pharmaceutical
Flamma vs

Ascend is an advanced therapy development partner with a flexible platform featuring industry-leadin...

Series A
101 employees
Biotechnology, Health and Wellness

FAQ About Flamma

Family owned & run. Advancing amino acids & small molecules since 1950. See why FLAMMA is The Thinking CDMO & follow us
Flamma was founded in 1950.
Flamma is headquartered in Italy.
Flamma operates in Biotechnology, Manufacturing and Pharmaceutical. Its work centres on cGMP manufacturing, small molecule APIs, NCEs and RSMs. Its customers include Pharmaceutical Companies, Biotech Firms and Drug Development Companies.
Flamma has a B2B and D2C business model. Its revenue comes from Service Fee, Product Sales and Consulting Fee.
Flamma has approximately 452 employees.
Flamma offers: Custom Manufacturing, Process Development, Analytical Validation, Commercial Manufacturing, Scale-up Capabilities, Regulatory Support.
Top alternatives and competitors to Flamma include Upperton Pharma Solutions, American Injectables, Ascend Advanced Therapies, JOINN Biologics US Inc., Kincell Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Flamma and Upperton Pharma Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Flamma, https://bouncewatch.com/company/flamma-group, updated 21 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout